Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial

Human papillomavirus (HPV) vaccines are efficacious against HPV infections and associated lesions in women HPV-naïve at vaccination. However, vaccine efficacy (VE) against oncogenic, high-risk HPV (HR-HPV) types in women infected with any other HR-HPV type at first vaccination (baseline) remains unc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Hu, Shangying, Xu, Xiaoqian, Zhu, Fengcai, Hong, Ying, Hu, Yuemei, Zhang, Xun, Pan, Qinjing, Zhang, Wenhua, Zhang, Chengfu, Yang, Xiaoping, Yu, Jiaxi, Zhu, Jiahong, Zhu, Yejiang, Chen, Feng, Zhao, Shuang, Karkada, Naveen, Tang, Haiwen, Bi, Dan, Struyf, Frank, Zhao, Fanghui
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018349/
https://ncbi.nlm.nih.gov/pubmed/33180670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1829411
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires